FDA Inspection
Altasciences CDMO Philadelphia, LLCAltasciences CDMO Philadelphia, LLC – FDA Inspection, Jul 26, 2024
Record Details
This FDA Inspection record concerns Altasciences CDMO Philadelphia, LLC, with an inspection on July 26, 2024, issued by the Center for Drug Evaluation and Research.
- Inspection Date
- July 26, 2024
View Company Profile
ID · 96576d5f-a691-4547-bb3d-cff60406b50b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1244787
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
FDA Citations
4- 21 CFR 211.130Procedures are written, and followed
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Altasciences CDMO Philadelphia, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 17, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 5, 2018 | Not classified | Philadelphia District Office | |
| February 18, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 16, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Altasciences CDMO Philadelphia, LLC
- FDA Inspection 1081264 - 2018-12-17
- FDA Inspection 1048710 - 2018-04-05
- FDA Inspection 866422 - 2014-02-18
- FDA Inspection 716884 - 2011-03-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.